Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makishima

Showing results (681-690 of 737) with videos related to

Pageof 74
Sort By:
Leukemia|May 31, 2017
Genomic determinants of chronic myelomonocytic leukemiaB J Patel, B Przychodzen, S Thota, et al.
Leukemia|September 14, 2018
Molecular pathogenesis of disease progression in MLL-rearranged AMLShinichi Kotani, Akinori Yoda, Ayana Kon, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 11, 2022
Carbon-ion radiotherapy versus radiofrequency ablation as initial treatment for early-stage hepatocellular carcinomaNaoto Fujita, Naoya Kanogawa, Hirokazu Makishima, et al.
International Cancer Conference Journal|April 3, 2026
Exploratory case series of conversion to carbon ion radiotherapy after systemic therapy in advanced hepatocellular carcinomaHaruka Anzai, Chihiro Miwa, Sadahisa Ogasawara, et al.
Blood|August 3, 2022
Clonal germinal center B cells function as a niche for T-cell lymphomaManabu Fujisawa, Tran B Nguyen, Yoshiaki Abe, et al.
British Journal of Haematology|September 24, 2021
Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseasesDaisuke Kaji, Manabu Kusakabe, Mamiko Sakata-Yanagimoto, et al.
Ejhaem|December 18, 2024
Association between microenvironment-related genes and prognosis of primary central nervous system lymphomaKeiichiro Hattori, Kenichi Makishima, Sakurako Suma, et al.
Plos One|August 21, 2012
Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosisFabiola Traina, Valeria Visconte, Anna M Jankowska, et al.
JHEP Reports : Innovation in Hepatology|March 29, 2026
MVI-targeted carbon-ion radiotherapy combined with immunotherapy for advanced hepatocellular carcinoma: Phase Ib DEPARTURE trialSadahisa Ogasawara, Keisuke Koroki, Hirokazu Makishima, et al.
Nature Communications|November 28, 2019
Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromesYasunobu Nagata, Hideki Makishima, Cassandra M Kerr, et al.
Pageof 74

Showing results (681-690 of 737) with videos related to

Sort By:
Pageof 74
Leukemia|May 31, 2017
Genomic determinants of chronic myelomonocytic leukemiaB J Patel, B Przychodzen, S Thota, et al.
Leukemia|September 14, 2018
Molecular pathogenesis of disease progression in MLL-rearranged AMLShinichi Kotani, Akinori Yoda, Ayana Kon, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 11, 2022
Carbon-ion radiotherapy versus radiofrequency ablation as initial treatment for early-stage hepatocellular carcinomaNaoto Fujita, Naoya Kanogawa, Hirokazu Makishima, et al.
International Cancer Conference Journal|April 3, 2026
Exploratory case series of conversion to carbon ion radiotherapy after systemic therapy in advanced hepatocellular carcinomaHaruka Anzai, Chihiro Miwa, Sadahisa Ogasawara, et al.
Blood|August 3, 2022
Clonal germinal center B cells function as a niche for T-cell lymphomaManabu Fujisawa, Tran B Nguyen, Yoshiaki Abe, et al.
British Journal of Haematology|September 24, 2021
Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseasesDaisuke Kaji, Manabu Kusakabe, Mamiko Sakata-Yanagimoto, et al.
Ejhaem|December 18, 2024
Association between microenvironment-related genes and prognosis of primary central nervous system lymphomaKeiichiro Hattori, Kenichi Makishima, Sakurako Suma, et al.
Plos One|August 21, 2012
Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosisFabiola Traina, Valeria Visconte, Anna M Jankowska, et al.
JHEP Reports : Innovation in Hepatology|March 29, 2026
MVI-targeted carbon-ion radiotherapy combined with immunotherapy for advanced hepatocellular carcinoma: Phase Ib DEPARTURE trialSadahisa Ogasawara, Keisuke Koroki, Hirokazu Makishima, et al.
Nature Communications|November 28, 2019
Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromesYasunobu Nagata, Hideki Makishima, Cassandra M Kerr, et al.
Pageof 74